AIM
BIVV

Advantage Investment Management’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Advantage Investment Management’s Portfolio BIVV Stock Details BIVV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-200
Closed -$11K – 1102
2017
Q4 		$11K Buy
+200
New +$10.9K ﹤0.01% 677

Other funds holding BIVV

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
ACS
Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Advantage Investment Management's BIVV Position: Q1 2018 in Review

Advantage Investment Management sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 200 shares — an estimated $11K sold.

Advantage Investment Management first reported a position in BIVV in Q4 2017 and held it in 1 quarter. The position peaked at $11K in Q4 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

  • Advantage Investment Management reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
  • Advantage Investment Management sold 200 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $11K.
  • Advantage Investment Management first reported a position in Bioverativ Inc. Common Stock in Q4 2017 and held it in 1 quarter.
  • Advantage Investment Management's Bioverativ Inc. Common Stock position peaked at $11K in Q4 2017.
  • 2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on Advantage Investment Management's 13F filing for Q1 2018, filed 15 May 2018.